Zoya Gluzman-Poltorak

Zoya Gluzman-Poltorak is an accomplished biotechnology professional with extensive experience in therapeutic development and strategic planning. As the owner of ZGP Consulting since June 2016, Zoya specializes in biotech therapeutic development. Zoya serves as an industry advisor to the SPARK program at Stanford University School of Medicine and as an advisor for Synkrino Development Company. Previously, Zoya held the role of Chief Development Officer at SonoThera and Vice President of Therapeutic Development at ASC Therapeutics, where Zoya pioneered the division focused on advanced AAV-based therapies. Zoya's career includes significant contributions to Neumedicines Inc. and consultancy roles with BIOFORUM and Genegrafts, alongside academia as an adjunct senior lecturer. Zoya's educational background includes a Ph.D. in Angiogenesis, Tumorogenesis, and Molecular Biology from the Technion - Israel Institute of Technology, complemented by an MBA and various degrees in biology and molecular biology.